Image_6_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_5_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_12_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_7_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_3_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_11_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_4_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_2_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Table_1_Prostate cancer epidemiology and prognostic factors in the United States.docx by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_8_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Table_1_Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.xlsx by B. Leticia Rodriguez (1953484)

Image_10_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Presentation_1_Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.pptx by B. Leticia Rodriguez (1953484)

Image_9_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_14_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_13_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Analysis of the bistable behavior of RMD neuron. by Martina Nicoletti (6900464)

“…<p><b>A) Steady-state I-V curves at varying .</b> Steady-state I-V curves are obtained from the currents computed during a voltage clamp stimulation with steps ranging between -90 mV and -10 mV, with 1 mV increments. …”

INFLUENCE OF THE MISDEF ALGORITHM ON THE THERAPEUTIC DECISION FOR VERTEBRAL DEFORMITY IN THE ADULT by GUILHERME ZANDAVALLI RAMOS (10417890)

The proposed mechanism whereby PPi protects against early electrical failure in the course of LDVF. by Junko Shibayama (387144)

Model response to touch. by Roman Vaxenburg (1501810)

“…Bottom: solid and dashed lines show the total whisker shape sampled with 0.5 ms steps during the increase and decrease of the force, respectively. …”